dc.contributor.author | Jonsson, Arnar J | |
dc.contributor.author | Lund, Sigrun H | |
dc.contributor.author | Eriksen, Bjørn Odvar | |
dc.contributor.author | Palsson, Runolfur | |
dc.contributor.author | Indridason, Olafur S | |
dc.date.accessioned | 2023-12-20T13:11:03Z | |
dc.date.available | 2023-12-20T13:11:03Z | |
dc.date.issued | 2023-02-09 | |
dc.description.abstract | Objectives. Prior studies on the association of estimated
glomerular filtration rate (eGFR) and mortality have failed to
include methods to account for repeated eGFR determinations.
The aim of this study was to estimate the association between
eGFR and mortality in the general population in Iceland
employing a joint model.<p>
<p>Methods. We obtained all serum creatinine and urine protein
measurements from all clinical laboratories in Iceland in the
years 2008–16. Clinical data were obtained from nationwide
electronic medical records. eGFR was calculated using the
Chronic Kidney Disease Epidemiology Collaboration equation
and categorized as follows: 0–29, 30–44, 45–59, 60–74, 75–
89, 90–104 and >104 mL/min/1.73 m2. A multiple imputation
method was used to account for missing urine protein
data. A joint model was used to assess risk of all-cause
mortality.
<p>Results. We obtained 2 120 147 creatinine values for 218 437
individuals, of whom 84 364 (39%) had proteinuria measurements available. Median age was 46 (range 18–106) years
and 47% were men. Proteinuria associated with increased
risk of death for all eGFR categories in persons of all
ages. In persons ≤65 years, the lowest risk was observed
for eGFR of 75–89 mL/min/1.73 m<sup>2</sup> without proteinuria.
For persons aged >65 years, the lowest risk was observed
for eGFR of 60–74 mL/min/1.73 m<sup>2</sup> without proteinuria.
eGFR of 45–59 mL/min/1.73 m<sup>2</sup> without proteinuria did not
associate with increased mortality risk in this age group. eGFR
>104 mL/min/1.73 m<sup>2</sup> associated with increased mortality.
<p>Conclusions. These results lend further support to the use
of age-adapted eGFR thresholds for defining chronic kidney
disease. Very high eGFR needs to be studied in more detail with
regard to mortality | en_US |
dc.identifier.citation | Jonsson, Lund, Eriksen, Palsson, Indridason. Association of eGFR and mortality with use of a joint model: results of a nationwide study in Iceland. Nephrology, Dialysis and Transplantation. 2023;38(10):2201-2212 | en_US |
dc.identifier.cristinID | FRIDAID 2196295 | |
dc.identifier.doi | 10.1093/ndt/gfad033 | |
dc.identifier.issn | 0931-0509 | |
dc.identifier.issn | 1460-2385 | |
dc.identifier.uri | https://hdl.handle.net/10037/32184 | |
dc.language.iso | eng | en_US |
dc.publisher | Oxford University Press | en_US |
dc.relation.journal | Nephrology, Dialysis and Transplantation | |
dc.rights.accessRights | openAccess | en_US |
dc.rights.holder | Copyright 2023 The Author(s) | en_US |
dc.rights.uri | https://creativecommons.org/licenses/by-nc/4.0 | en_US |
dc.rights | Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) | en_US |
dc.title | Association of eGFR and mortality with use of a joint model: results of a nationwide study in Iceland | en_US |
dc.type.version | publishedVersion | en_US |
dc.type | Journal article | en_US |
dc.type | Tidsskriftartikkel | en_US |
dc.type | Peer reviewed | en_US |